BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37495706)

  • 21. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.
    Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S
    World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
    Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
    J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability of Semi-Automated Segmentations in Glioblastoma.
    Huber T; Alber G; Bette S; Boeckh-Behrens T; Gempt J; Ringel F; Alberts E; Zimmer C; Bauer JS
    Clin Neuroradiol; 2017 Jun; 27(2):153-161. PubMed ID: 26490369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics-based evaluation and possible characterization of dynamic contrast enhanced (DCE) perfusion derived different sub-regions of Glioblastoma.
    Suhail Parvaze ; Bhattacharjee R; Singh A; Ahlawat S; Patir R; Vaishya S; Shah TJ; Gupta RK
    Eur J Radiol; 2023 Feb; 159():110655. PubMed ID: 36577183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced magnetic resonance imaging in glioblastoma: a review.
    Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
    Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
    Nöth U; Tichy J; Tritt S; Bähr O; Deichmann R; Hattingen E
    NMR Biomed; 2020 Mar; 33(3):e4242. PubMed ID: 31880005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.
    Samani ZR; Parker D; Wolf R; Hodges W; Brem S; Verma R
    Sci Rep; 2021 Jul; 11(1):14469. PubMed ID: 34262079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasari-Based Features Nomogram to Predict the Tumor-Infiltrating CD8+ T Cell Levels in Glioblastoma.
    Xue C; Zhou Q; Zhang B; Ke X; Zhang P; Liu X; Li S; Deng J; Zhou J
    Acad Radiol; 2024 May; 31(5):2050-2060. PubMed ID: 37985291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of glioblastoma by contrast-enhanced flair sequences.
    Aprile I; Giorgi C; Guiducci A; Conti G; Ottaviano I; Ottaviano P
    Neuroradiol J; 2008 Apr; 21(2):196-203. PubMed ID: 24256826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study.
    Verma R; Hill VB; Statsevych V; Bera K; Correa R; Leo P; Ahluwalia M; Madabhushi A; Tiwari P
    AJNR Am J Neuroradiol; 2022 Aug; 43(8):1115-1123. PubMed ID: 36920774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal restriction spectrum imaging is resistant to pseudoresponse in patients with high-grade gliomas treated with bevacizumab.
    Kothari P; White NS; Farid N; Chung R; Kuperman JM; Girard HM; Shankaranarayanan A; Kesari S; McDonald CR; Dale AM
    AJNR Am J Neuroradiol; 2013 Sep; 34(9):1752-1757. PubMed ID: 23578667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of Radiomics-Based Feature Analysis on Multiparametric Magnetic Resonance Images for Noninvasive Meningioma Grading.
    Laukamp KR; Shakirin G; Baeßler B; Thiele F; Zopfs D; Große Hokamp N; Timmer M; Kabbasch C; Perkuhn M; Borggrefe J
    World Neurosurg; 2019 Dec; 132():e366-e390. PubMed ID: 31476455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
    Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
    Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.
    Kamimura K; Kamimura Y; Nakano T; Hasegawa T; Nakajo M; Yamada C; Akune K; Ejima F; Ayukawa T; Ito S; Nagano H; Takumi K; Nakajo M; Uchida H; Tabata K; Iwanaga T; Imai H; Feiweier T; Yoshiura T
    Cancer Imaging; 2023 Aug; 23(1):75. PubMed ID: 37553578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
    Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
    J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.